News Valneva Receives Marketing Authorization in Europe for Inactivated Whole-Virus COVID-19 Vaccine VLA2001 Staff June 25, 2022 Iframe sync Post navigation Previous: New development dynamics and confirmed business strategyNext: NFL BIOSCIENCES TO PRESENT AT THE H.C.WAINWRIGHT 1ST ANNUAL MENTAL HEALTH CONFERENCE More Stories Healthcare News Pharmaceutical Queue Ventures Announces Closing of Brokered Private Placement of Subscription Receipts of Custom Fundco Inc. Staff December 5, 2025 Healthcare News Pharmaceutical Queue Ventures Announces Closing of Brokered Private Placement of Subscription Receipts of Custom Fundco Inc. Staff December 5, 2025 Coronavirus COVID-19 News Patient Care Predictmedix AI Announces Closing of Final Tranche of Non-Brokered Private Placement Staff December 5, 2025
